Headache Assessment and Management
- 19 March 2003
- journal article
- contempo updates
- Published by American Medical Association (AMA)
- Vol. 289 (11) , 1430-1433
- https://doi.org/10.1001/jama.289.11.1430
Abstract
The lifetime prevalence of headache is more than 90%.1 In recent population-based surveys of US adults, nearly 25% annually report recurrent episodes of severe headache and 4% daily or near-daily headache.2-4 Prescription or nonprescription products are used by 9% of US adults each week to treat headache, matching hypertension as the primary reason for medication use.5 The majority of patients presenting to physicians will have primary headache syndromes such as tension-type, cluster, and migraine. Less than 2% of patients in office and 4% of patients in emergency department settings will be found to have headaches secondary to significant pathology.6Keywords
This publication has 21 references indexed in Scilit:
- Preparedness of Internal Medicine and Family Practice Residents for Treating Common ConditionsPublished by American Medical Association (AMA) ,2002
- Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine HeadacheAnnals of Internal Medicine, 2002
- Costs and Outcomes of Early Versus Delayed Migraine Treatment with SumatriptanHeadache: The Journal of Head and Face Pain, 2002
- Recent Patterns of Medication Use in the Ambulatory Adult Population of the United StatesJAMA, 2002
- Tension-type headacheCurrent Treatment Options in Neurology, 2001
- Stratified Care vs Step Care Strategies for MigraineJAMA, 2000
- Prevalence of Frequent Headache in a Population SampleHeadache: The Journal of Head and Face Pain, 1998
- Practice parameterNeurology, 1995
- Effects of the Serotonin-Receptor Agonist Sumatriptan on Postdural Puncture HeadacheAnesthesia & Analgesia, 1994
- Epidemiology of headache in a general population—A prevalence studyJournal of Clinical Epidemiology, 1991